IBDEI06Z ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,3089,2)
 ;;=^84844
 ;;^UTILITY(U,$J,358.3,3090,0)
 ;;=250.80^^33^272^5
 ;;^UTILITY(U,$J,358.3,3090,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3090,1,4,0)
 ;;=4^250.80
 ;;^UTILITY(U,$J,358.3,3090,1,5,0)
 ;;=5^DM Type II w/ LE Ulcer
 ;;^UTILITY(U,$J,358.3,3090,2)
 ;;=DM Type II with LE Ulcer^267846^707.10
 ;;^UTILITY(U,$J,358.3,3091,0)
 ;;=250.00^^33^272^3
 ;;^UTILITY(U,$J,358.3,3091,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3091,1,4,0)
 ;;=4^250.00
 ;;^UTILITY(U,$J,358.3,3091,1,5,0)
 ;;=5^DM Typ II w/o Complications
 ;;^UTILITY(U,$J,358.3,3091,2)
 ;;=^33605
 ;;^UTILITY(U,$J,358.3,3092,0)
 ;;=250.40^^33^272^6
 ;;^UTILITY(U,$J,358.3,3092,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3092,1,4,0)
 ;;=4^250.40
 ;;^UTILITY(U,$J,358.3,3092,1,5,0)
 ;;=5^DM Type II w/ Nephropathy
 ;;^UTILITY(U,$J,358.3,3092,2)
 ;;=^267837^583.81
 ;;^UTILITY(U,$J,358.3,3093,0)
 ;;=250.50^^33^272^8
 ;;^UTILITY(U,$J,358.3,3093,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3093,1,4,0)
 ;;=4^250.50
 ;;^UTILITY(U,$J,358.3,3093,1,5,0)
 ;;=5^DM Type II w/ PDR
 ;;^UTILITY(U,$J,358.3,3093,2)
 ;;=DM Type II w/ PDR^267839^362.02
 ;;^UTILITY(U,$J,358.3,3094,0)
 ;;=250.60^^33^272^7
 ;;^UTILITY(U,$J,358.3,3094,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3094,1,4,0)
 ;;=4^250.60
 ;;^UTILITY(U,$J,358.3,3094,1,5,0)
 ;;=5^DM Type II w/ Neuropathy
 ;;^UTILITY(U,$J,358.3,3094,2)
 ;;=^267841^357.2
 ;;^UTILITY(U,$J,358.3,3095,0)
 ;;=250.70^^33^272^9
 ;;^UTILITY(U,$J,358.3,3095,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3095,1,4,0)
 ;;=4^250.70
 ;;^UTILITY(U,$J,358.3,3095,1,5,0)
 ;;=5^DM Type II w/ Peripheral Vasc Dis
 ;;^UTILITY(U,$J,358.3,3095,2)
 ;;=^267843^443.81
 ;;^UTILITY(U,$J,358.3,3096,0)
 ;;=250.01^^33^272^4
 ;;^UTILITY(U,$J,358.3,3096,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3096,1,4,0)
 ;;=4^250.01
 ;;^UTILITY(U,$J,358.3,3096,1,5,0)
 ;;=5^DM Type I w/o Complications
 ;;^UTILITY(U,$J,358.3,3096,2)
 ;;=^33586
 ;;^UTILITY(U,$J,358.3,3097,0)
 ;;=272.0^^33^272^21
 ;;^UTILITY(U,$J,358.3,3097,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3097,1,4,0)
 ;;=4^272.0
 ;;^UTILITY(U,$J,358.3,3097,1,5,0)
 ;;=5^Hypercholesterolemia, Pure
 ;;^UTILITY(U,$J,358.3,3097,2)
 ;;=Hypercholesterolemia, Pure^59973
 ;;^UTILITY(U,$J,358.3,3098,0)
 ;;=272.1^^33^272^25
 ;;^UTILITY(U,$J,358.3,3098,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3098,1,4,0)
 ;;=4^272.1
 ;;^UTILITY(U,$J,358.3,3098,1,5,0)
 ;;=5^Hypertriglyceridemia, Pure
 ;;^UTILITY(U,$J,358.3,3098,2)
 ;;=Hypertriglyceridemia, Pure^101303
 ;;^UTILITY(U,$J,358.3,3099,0)
 ;;=275.42^^33^272^20
 ;;^UTILITY(U,$J,358.3,3099,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3099,1,4,0)
 ;;=4^275.42
 ;;^UTILITY(U,$J,358.3,3099,1,5,0)
 ;;=5^Hypercalcemia
 ;;^UTILITY(U,$J,358.3,3099,2)
 ;;=^59932
 ;;^UTILITY(U,$J,358.3,3100,0)
 ;;=275.41^^33^272^26
 ;;^UTILITY(U,$J,358.3,3100,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3100,1,4,0)
 ;;=4^275.41
 ;;^UTILITY(U,$J,358.3,3100,1,5,0)
 ;;=5^Hypocalcemia
 ;;^UTILITY(U,$J,358.3,3100,2)
 ;;=^60542
 ;;^UTILITY(U,$J,358.3,3101,0)
 ;;=276.7^^33^272^22
 ;;^UTILITY(U,$J,358.3,3101,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3101,1,4,0)
 ;;=4^276.7
 ;;^UTILITY(U,$J,358.3,3101,1,5,0)
 ;;=5^Hyperkalemia
 ;;^UTILITY(U,$J,358.3,3101,2)
 ;;=^60042
 ;;^UTILITY(U,$J,358.3,3102,0)
 ;;=275.2^^33^272^18
 ;;^UTILITY(U,$J,358.3,3102,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3102,1,4,0)
 ;;=4^275.2
 ;;^UTILITY(U,$J,358.3,3102,1,5,0)
 ;;=5^Hyper Or Hypomagnesemia
 ;;^UTILITY(U,$J,358.3,3102,2)
 ;;=^35626
 ;;^UTILITY(U,$J,358.3,3103,0)
 ;;=276.0^^33^272^23
 ;;^UTILITY(U,$J,358.3,3103,1,0)
 ;;=^358.31IA^5^2
